SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
25-Feb-19 4:38 PM View: | Pro-Pharmaceuticals Inc. (GALT) | 22-Feb-19 | Option Exercise | 859 | $2.39 | $2,053.01 | 6% 13.58K to 14.44K | |
25-Feb-19 4:38 PM View: | Pro-Pharmaceuticals Inc. (GALT) | 22-Feb-19 | Market Sale (Planned) | 859 | $6.02 | $5,174.96 | (6%) 14.44K to 13.58K | 37% |
25-Feb-19 4:38 PM View: | Pro-Pharmaceuticals Inc. (GALT) | 21-Feb-19 | Option Exercise | 43,326 | $2.39 | $103,549.00 | 211% 20.58K to 63.91K | |
25-Feb-19 4:38 PM View: | Pro-Pharmaceuticals Inc. (GALT) | 21-Feb-19 | Market Option Sale (Planned) | 44,185 | $6.02 | $266,050.00 | (69%) 63.91K to 19.72K | 37% |
25-Feb-19 4:38 PM View: | Pro-Pharmaceuticals Inc. (GALT) | 21-Feb-19 | Market Sale (Planned) | 6,141 | $6.02 | $36,976.60 | (31%) 19.72K to 13.58K | 37% |
25-Jan-19 4:38 PM View: | Curis Inc. (CRIS) | 23-Jan-19 | Market Sale (Planned) | 18,500 | $1.05 | $19,476.80 | (39%) 47.32K to 28.82K | (693%) |
25-Sep-18 7:02 PM View: | Titan Pharmaceuticals Inc. (TTNP) | 21-Sep-18 | Market Purchase | 400,000 | $0.25 | $100,000.00 | 256% 156.32K to 556.32K | |
06-Sep-18 4:24 PM View: | Pro-Pharmaceuticals Inc. (GALT) | 04-Sep-18 | Option Exercise | 6,000 | -- | -- | 23% 26.48K to 32.48K | |
06-Sep-18 4:24 PM View: | Pro-Pharmaceuticals Inc. (GALT) | 04-Sep-18 | Market Option Sale (Planned) | 6,000 | $6.58 | $39,456.60 | (18%) 32.48K to 26.48K | 42% |
06-Sep-18 4:24 PM View: | Pro-Pharmaceuticals Inc. (GALT) | 04-Sep-18 | Market Sale (Planned) | 5,900 | $6.58 | $38,799.00 | (22%) 26.48K to 20.58K | 42% |
04-Sep-18 4:08 PM View: | Pro-Pharmaceuticals Inc. (GALT) | 30-Aug-18 | Option Exercise | 29,000 | -- | -- | 52% 55.58K to 84.58K | |
04-Sep-18 4:08 PM View: | Pro-Pharmaceuticals Inc. (GALT) | 30-Aug-18 | Market Option Sale (Planned) | 29,000 | $6.08 | $176,352.00 | (34%) 84.58K to 55.58K | 37% |
04-Sep-18 4:08 PM View: | Pro-Pharmaceuticals Inc. (GALT) | 30-Aug-18 | Market Sale (Planned) | 29,100 | $6.08 | $176,960.00 | (52%) 55.58K to 26.48K | 37% |
24-Jan-18 4:45 PM View: | Curis Inc. (CRIS) | 22-Jan-18 | Grant | 185,000 | -- | -- | 359% 51.6K to 236.6K | |
08-Dec-17 2:26 PM View: | Pro-Pharmaceuticals Inc. (GALT) | 08-Dec-17 | Market Purchase | 7,000 | $1.85 | $12,971.70 | 14% 48.58K to 55.58K | 106% |
16-Nov-17 2:02 PM View: | Curis Inc. (CRIS) | 16-Nov-17 | Market Purchase | 25,000 | $0.98 | $24,500.00 | 94% 26.6K to 51.6K | 70% |
11-Jan-16 5:58 PM View: | Titan Pharmaceuticals Inc. (TTNP) | 11-Jan-16 | Market Purchase | 5,000 | $3.25 | $16,250.00 | 3% 151.32K to 156.32K | |
31-Aug-15 5:19 PM View: | Titan Pharmaceuticals Inc. (TTNP) | 28-Aug-15 | Market Purchase | 50,000 | $0.71 | $35,750.00 | 6% 782.2K to 832.2K | (69%) |
08-Jul-15 5:00 PM View: | Pro-Pharmaceuticals Inc. (GALT) | 21-May-15 | Grant | 2,768 | -- | -- | 6% 45.81K to 48.58K | |
08-Jul-15 5:00 PM View: | Pro-Pharmaceuticals Inc. (GALT) | 08-Apr-15 | Grant | 28,367 | -- | -- | 163% 17.45K to 45.81K | |
08-Jul-15 5:00 PM View: | Pro-Pharmaceuticals Inc. (GALT) | 12-Mar-15 | Grant | 11,112 | -- | -- | 175% 6.33K to 17.45K | |
14-Oct-14 12:13 PM View: | Titan Pharmaceuticals Inc. (TTNP) | 09-Oct-14 | Market Purchase | 100,000 | $0.48 | $48,200.00 | 16% 607.2K to 707.2K | (54%) |
14-Feb-14 4:57 PM View: | Titan Pharmaceuticals Inc. (TTNP) | 12-Feb-14 | Grant | 100,000 | $0.66 | $66,000.00 | 17% 582.2K to 682.2K | (66%) |
04-Dec-13 5:29 PM View: | Pro-Pharmaceuticals Inc. (GALT) | 04-Dec-13 | Market Purchase | 3,000 | $8.69 | $26,070.00 | 90% 3.33K to 6.33K | (56%) |
19-Jun-13 3:51 PM View: | Titan Pharmaceuticals Inc. (TTNP) | 17-Jun-13 | Market Purchase | 50,000 | $0.45 | $22,690.00 | 12% 413.4K to 463.4K | 61% |
21-Nov-11 5:22 PM View: | Titan Pharmaceuticals Inc. (TTNP) | 18-Nov-11 | Market Purchase | 38,400 | $1.27 | $48,917.80 | 10% 375.0K to 413.4K | (44%) |
20-Oct-11 11:36 AM View: | Pro-Pharmaceuticals Inc. (GALT) | 18-Oct-11 | Market Purchase | 20,000 | $0.96 | $19,200.00 | 100% 0 to 20.0K | (31%) |
14-Dec-10 2:04 PM View: | Curis Inc. (CRIS) | 10-Dec-10 | Market Purchase | 26,596 | $1.89 | $50,266.40 | 100% 0 to 26.6K | (9%) |
22-Oct-08 5:46 PM View: | Titan Pharmaceuticals Inc. (TTNP) | 21-Oct-08 | Grant | 400,000 | -- | -- | 308% 130.0K to 530.0K | |
07-Feb-08 4:29 PM View: | Titan Pharmaceuticals Inc. (TTNP) | 07-Feb-08 | Market Purchase | 5,000 | $1.30 | $6,514.10 | 4% 125.0K to 130.0K | (98%) |
07-Feb-08 4:29 PM View: | Titan Pharmaceuticals Inc. (TTNP) | 06-Feb-08 | Market Purchase | 15,000 | $1.31 | $19,700.00 | 14% 110.0K to 125.0K | (98%) |
07-Feb-08 4:29 PM View: | Titan Pharmaceuticals Inc. (TTNP) | 05-Feb-08 | Market Purchase | 10,000 | $1.38 | $13,800.00 | 10% 100.0K to 110.0K | (98%) |